Safety, Tolerability, and Pharmacokinetics of Single and Repeat Doses of Nemiralisib Administered via the Ellipta Dry Powder Inhaler to Healthy Subjects

Robert C. Wilson, Emily Jarvis, Mickaël Montembault, J. Hamblin, Edith M. Hessel, Anthony CahnClinical 2018 · DOI

BibTeX
@inproceedings{wilson2018safety,
  author = {Robert C. Wilson and Emily Jarvis and Mickaël Montembault and J. Hamblin and Edith M. Hessel and Anthony Cahn},
  title = {{Safety, Tolerability, and Pharmacokinetics of Single and Repeat Doses of Nemiralisib Administered via the Ellipta Dry Powder Inhaler to Healthy Subjects}},
  booktitle = {Clinical},
  year = {2018},
  doi = {10.1016/j.clinthera.2018.06.011},
}

Loading related content...

Figure